Skip to content

3D Placental Volume in Placenta Accreta

3D Ultrasound Placental Volume and Vascular Indices Versus 2D Parameters for Diagnosis of Placenta Accreta Spectrum

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06755047
Enrollment
38
Registered
2025-01-01
Start date
2024-12-31
Completion date
2025-05-31
Last updated
2025-01-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Accreta

Brief summary

Placenta Accreta spectrum is a major obstetric disease nowadays. Different methods are used for antenatal diagnosis. In our study, investigators are aiming to compare 2 common ways for diagnosis, i.e; 3D Ultrasound and 2D with color Doppler.

Detailed description

The word placenta accreta spectrum disorders (PASD) implies an atypical implantation of the placenta into the uterine wall and has been used to express placenta accreta, increta and percreta. Placenta accreta is a placenta where the placental villi sick on directly to the myometrium. Placenta increta is a placenta where the placental villi attack into the myometrium and placenta percreta is a placenta where the villi invade through the myometrium and into serosa. No antenatal diagnostic method gives the clinician 100% assurance of either ruling in or ruling out the existence of placenta accreta. The definitive diagnosis of placental accreta spectrum is frequently ended postpartum on hysterectomy specimens when an area of accretion shows chorionic villi which make direct contact with the myometrium and absence of deciduae. Antenatal ultrasound is the method of choice used to establish the diagnosis and direct clinical management.The combined use of power Doppler with three dimensional (3D) ultrasound provides the possibility of quantifying moving blood within a volume of interest. Three indices are calculated, namely vascularization index (VI), flow index and vascularization flow index

Interventions

RADIATION3D Ultrasound

3D placental volume and vascular indices

RADIATION2D ultrasound

2D placental criteria of invasion and color Doppler

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* pregnant women with placenta previa

Exclusion criteria

* congenital anomalies of placenta Placental separation Uterine anomalies

Design outcomes

Primary

MeasureTime frameDescription
Vascular index1 months3D Vascularization index

Secondary

MeasureTime frameDescription
2D ultrasound1 monthsmyometrial thinning (\>1mm),

Countries

Egypt

Contacts

Primary ContactMohamed Fekry, PhD
mohamedbeethoven2040@gmail.com0882312

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026